Abstract
Malignant tumors remain virtually untreatable and inevitably lethal despite extensive surgical excision and adjuvant radio- and chemotherapy. Therefore, the development of more effective tumor-selective therapies is necessary. Stem/progenitorcells that self-renew, differentiate and display inherent tumor-tropic properties can be exploited for targeted delivery of therapeutic genes to invasive and metastatic tumors. In this review, we mainly introduce the application in Glioma, Breast cancer, Spinal cord injury, AD and so on. The promising field of stem cell research as it applies to regenerative medicine is still in infancy, but its potential appears limitless, and we are blessed to be involved in this exciting realm of research.
Keywords: Stem/progenitor cells, malignant tumors, gene therapy, antibody neural disorder, chemotherapy, metastatic tumors, Breast cancer, Spinal cord injury, stem cell, The nervous system, neural stem cells, fetal tissue, human ntera 2 neurons, gene products
Current Pharmaceutical Biotechnology
Title:Therapeutic Gene Products Delivery by Neuron Stem Cells
Volume: 13 Issue: 12
Author(s): Jie Tan, Yanna Meng, Shiang Huang and Ping Wang
Affiliation:
Keywords: Stem/progenitor cells, malignant tumors, gene therapy, antibody neural disorder, chemotherapy, metastatic tumors, Breast cancer, Spinal cord injury, stem cell, The nervous system, neural stem cells, fetal tissue, human ntera 2 neurons, gene products
Abstract: Malignant tumors remain virtually untreatable and inevitably lethal despite extensive surgical excision and adjuvant radio- and chemotherapy. Therefore, the development of more effective tumor-selective therapies is necessary. Stem/progenitorcells that self-renew, differentiate and display inherent tumor-tropic properties can be exploited for targeted delivery of therapeutic genes to invasive and metastatic tumors. In this review, we mainly introduce the application in Glioma, Breast cancer, Spinal cord injury, AD and so on. The promising field of stem cell research as it applies to regenerative medicine is still in infancy, but its potential appears limitless, and we are blessed to be involved in this exciting realm of research.
Export Options
About this article
Cite this article as:
Tan Jie, Meng Yanna, Huang Shiang and Wang Ping, Therapeutic Gene Products Delivery by Neuron Stem Cells, Current Pharmaceutical Biotechnology 2012; 13 (12) . https://dx.doi.org/10.2174/138920112803341806
DOI https://dx.doi.org/10.2174/138920112803341806 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Host Pharmacogenetics in the Treatment of HIV and Cancer
Current Drug Safety Gene Therapy Targeting in the Central Nervous System
Current Gene Therapy Purinergic Signaling and Energy Homeostasis in Psychiatric Disorders
Current Molecular Medicine Antiangiogenic Gene Therapy in Cancer
Current Genomics Nanodiamonds as a New Horizon for Pharmaceutical and Biomedical Applications
Current Drug Delivery Disintegrins
Current Drug Targets - Cardiovascular & Hematological Disorders Feasibility of Targeting Glioblastoma Stem Cells: From Concept to Clinical Trials
Current Topics in Medicinal Chemistry Potassium Channels are a New Target Field in Anticancer Drug Design
Recent Patents on Anti-Cancer Drug Discovery Novel Biomarkers of microRNAs in Gastric Cancer: An Overview from Diagnosis to Treatment
MicroRNA Oncolytic Coxsackievirus and the Mechanisms of its Effects on Cancer: A Narrative Review
Current Cancer Therapy Reviews In vivo Near-infrared Fluorescence Tumor Imaging Using DiR-loaded Nanocarriers
Current Drug Delivery Recent Patents on Mesenchymal Stem Cell Mediated Therapy in Inflammatory Diseases
Recent Patents on Inflammation & Allergy Drug Discovery A Role of Immunotherapy in Metastatic Malignant Melanoma
Central Nervous System Agents in Medicinal Chemistry The CCL2/CCR2 Axis in the Pathogenesis of HIV-1 Infection: A New Cellular Target for Therapy?
Current Drug Targets Adenovirus Vector Production and Purification
Current Gene Therapy Target Therapies in Pancreatic Carcinoma
Current Medicinal Chemistry Recent Developments of Phototherapy Based on Graphene Family Nanomaterials
Current Medicinal Chemistry Stem Cells as Delivery Vehicles for Oncolytic Adenoviral Virotherapy
Current Gene Therapy Meet Our Associate Editor
Current Molecular Medicine Quantitative Structure – Activity Relationship Study on Saponins as Cytotoxicity Enhancers
Letters in Drug Design & Discovery